ExoPTEN
Acute Spinal Cord Injury
PreclinicalActive
Key Facts
About NurExone Biologic
Exosome‑powered regenerative therapies for CNS injuries, leveraging a scalable nanodrug platform.
View full company profileTherapeutic Areas
Other Acute Spinal Cord Injury Drugs
| Drug | Company | Phase |
|---|---|---|
| AMFX-200S | Amphix Bio | Preclinical |
| ES135 | Eusol Biotech | Phase 3 |
| OPC1 | Lineage Cell Therapeutics | Phase 1/2a |